SC 13G: Celldex Therapeutics, Inc.
Ticker: CLDX · Form: SC 13G · Filed: Feb 14, 2024 · CIK: 744218
| Field | Detail |
|---|---|
| Company | Celldex Therapeutics, Inc. (CLDX) |
| Form Type | SC 13G |
| Filed Date | Feb 14, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Celldex Therapeutics, Inc..
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G filing submitted by Celldex Therapeutics, Inc. (ticker: CLDX) to the SEC on Feb 14, 2024.
What is the risk level of this SC 13G filing?
This filing has been assessed as low risk.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (ame of Issuer) Common Stock, par value $0.001 (Title of Class of Securities) 15117B).
How long is this filing?
Celldex Therapeutics, Inc.'s SC 13G filing is 4 pages with approximately 1,251 words. Estimated reading time is 5 minutes.
Where can I view the full SC 13G filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 1,251 words · 5 min read · ~4 pages · Grade level 9 · Accepted 2024-02-14 12:52:38
Key Financial Figures
- $0.001 — ame of Issuer) Common Stock, par value $0.001 (Title of Class of Securities) 15117B
Filing Documents
- cldx_21424.htm (SC 13G) — 42KB
- 0001085146-24-001357.txt ( ) — 43KB
(a)
ITEM 1(a). NAME OF ISSUER: Celldex Therapeutics, Inc.
(b)
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 53 Frontage Road, Suite 220 Hampton, NJ, USA 08827
(a)
ITEM 2(a). NAME OF PERSON FILING: Kynam Capital Management, LP Kynam Capital Management GP, LLC Yue Tang
(b)
ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 221 Elm Road. Princeton, NJ 08540
(c)
ITEM 2(c). CITIZENSHIP: Delaware Delaware U.S.
(d)
ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock, par value $0.001
(e)
ITEM 2(e). CUSIP NUMBER: 15117B202 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c); (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) [X] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution: ITEM 4. (a) Amount beneficially owned: 3,005,904 (b) Percent of class: 5.5% (c) Number of shares as to which the person has: (i) sole power to vote or to direct the vote: Kynam Capital Management, LP : Kynam Capital Management GP, LLC : Yue Tang : (ii) shared power to vote or to direct the vote: Kynam Capital Management, LP : 3,005,904 Kynam Capital Management GP, LLC : 3,005,904 Yue Tang : 3,005,904 (iii) sole power to dispose or direct the disposition of: Kynam Capital Management, LP : Kynam Capital Management GP, LLC : Yue Tang : (iv) shared power to dispose or to direct the disposition of: Kyn